Table 1.

Clinical characteristics and IVF-ET data

	Control	DNG	p
Patients (n)	34	30
Age (years)	33.6 ± 3.6	34.2 ± 3.4	ns
Stage of endometriosis rASRM (III)	9	10
rASRM (IV)	5	6
Serum CA125 (U/ml) (before DNG)	–	44.2 ± 35.3
Serum CA125 (U/ml)	26.4 ± 16.8	29.1 ± 26.9	ns
Gonadotropin (FSH/HMG) dose (IU)	1304 ± 338	1553 ± 528	P < 0.05
Estradiol (pg/ml)	1731 ± 958	1288 ± 1091	P < 0.05
Progesterone (ng/ml)	1.11 ± 1.14	1.72 ± 2.0	ns
Follicles ≥15 mm (n)	6.5 ± 4.2	4.6 ± 3.2	P < 0.05

IVF-ET In vitro fertilization and embryo transfer, DNG Dienogest